Commentary
Emerging roles in prolactin-mediated BRCA1 function
Abstract
In a recent issue of Cancer Letters, Chen et al. reported that prolactin may inhibit a major tumor-suppressive function of BRCA1 by interfering with the BRCA1-related cell cycle inhibitor, p21 (1). These findings are interesting and will open up a controversial discussion on the role of prolactin in tumorigenesis.